Sera Prognostics, Inc. (SERA)
Develops blood tests to predict pregnancy complications before they happen.
$2.03-0.01%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago-24.8%
The outlook
SERA is trading near the lower end of its 52-week range at $2.03. Analyst coverage shows a notably optimistic average price target around 171% above the current price, though the stock's mixed positioning relative to its moving averages reflects uncertain near-term momentum. Overall sentiment leans neutral.
What’s behind the score
Price trendMixed vs its moving averages
52-week range20% of the way from its 52-week low to high
Price targetAvg target +171% vs current price
Analyst price target
~12-month · 2 analysts$5.50average target+170.9% vs now
Now $2.03
Low $5.00High $6.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$79.5M
52-wk high
$3.95
52-wk low
$1.56
50-day avg
$1.99
200-day avg
$2.54
Trailing P/E
—